This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday

Baidu, Inc. Sponsored ADR Class A
Bank of Montreal
Ionis Pharmaceuticals, Inc.
KE Holdings
BioMarin Pharmaceutical Inc.

Baidu, Inc. Sponsored ADR Class A

BIDU

0.00

Bank of Montreal

BMO

0.00

Ionis Pharmaceuticals, Inc.

IONS

0.00

KE Holdings

BEKE

0.00

BioMarin Pharmaceutical Inc.

BMRN

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Gary Yu downgraded Baidu Inc (NASDAQ:BIDU) from Equal-Weight to Underweight and cut the price target from $130 to $80. Baidu closed at $90.87 on Tuesday. See how other analysts view this stock.
  • CIBC analyst Paul Holden downgraded Bank of Montreal (TSX:BMO) from Outperformer to Neutral and raised the price target from C$244 to C$272. See how other analysts view this stock.
  • JP Morgan analyst Sebastiano Petti downgraded Cogent Communications Holdings Inc (NASDAQ:CCOI) from Neutral to Underweight and cut the price target from $22 to $9. Cogent Communications closed at $10.13 on Tuesday. See how other analysts view this stock.
  • Jefferies analyst Jack Slevin downgraded Pediatrix Medical Group Inc (NYSE:MD) from Buy to Hold and raised the price target from $27 to $28. Pediatrix Medical Group shares closed at $26.56 on Tuesday. See how other analysts view this stock.
  • UBS analyst George Eadie downgraded Core Natural Resources Inc (NYSE:CNR) from Buy to Neutral and raised the price target from $101 to $105. Core Natural Resources closed at $92.03 on Tuesday. See how other analysts view this stock.

Considering buying BIDU stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.